May 27, 2016 4:21 PM ET


Company Overview of Juno Therapeutics Inc.

Executive Profile

Mark W. Frohlich M.D.

Executive Vice President of Portfolio Strategy, Juno Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 2 different industries.

As of Fiscal Year 2015


Dr. Mark W. Frohlich, M.D. has been an Executive Vice President of Portfolio Strategy at Juno Therapeutics Inc. since February 29, 2016 and served as its Executive Vice President of Research & Development since February 2014. Dr. Frohlich has more than two decades of experience in the field of immuno-oncology. Dr. Frohlich served as the Chief Medical Officer of Dendreon Corp. since January 2008 until February 1, 2014 and as its Executive Vice President of Research and ...

Corporate Headquarters

307 Westlake Avenue North
Seattle, Washington 98109

United States

Phone: 206-582-1600
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.


Yale University
Harvard Medical School
Post-Doctoral Training
University of California-San Francisco

Other Affiliations

Annual Compensation

Total Annual Compensation$400,000

Stocks Options

Exercisable Options$9,468
Unexercisable Options$41,032
Total Number of Options$50,500

Total Compensation

Total Annual Cash Compensation$560,000
Total Short Term Compensation$400,000
Total Calculated Compensation$2,164,890

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Randal J. Kirk J.D.Chairman, Chief Executive Officer and President
Intrexon Corporation
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Juno Therapeutics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at